Literature DB >> 9623751

Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder.

G B Forbes1.   

Abstract

Ability of the Test of Variables of Attention (TOVA) to distinguish between referred children with attention-deficit/hyperactivity disorder (ADHD) and other (OTHER) clinical diagnoses were studied. The ADHD group differed from the OTHER group on TOVA variables and most measures from the Revised Conners Teacher Rating Scale (RCTRS) and ADD-H Comprehensive Teacher's Rating Scale (ACTeRS). The criteria of any one TOVA variable > 1.5 standard deviations from age and sex adjusted means correctly identified 80% of the sample with attention deficit disorders and 72% of the sample without attention deficit disorder. Cases misclassified by teacher ratings were often correctly classified by the TOVA and conversely. The TOVA makes a unique and important contribution to diagnostic evaluations.

Entities:  

Mesh:

Year:  1998        PMID: 9623751     DOI: 10.1002/(sici)1097-4679(199806)54:4<461::aid-jclp8>3.0.co;2-q

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  24 in total

1.  A practical approach to objective attention deficit/hyperactivity disorder diagnosis and management.

Authors:  C Thomas Gualtieri
Journal:  Psychiatry (Edgmont)       Date:  2005-07

2.  Attention deficit hyperactivity disorder - Medical malady or societal madness?

Authors:  Basil Porter
Journal:  Paediatr Child Health       Date:  2002-12       Impact factor: 2.253

3.  Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Authors:  Sharon B Wigal; Tim Wigal; Sabrina Schuck; Matthew Brams; David Williamson; Robert B Armstrong; H Lynn Starr
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-13       Impact factor: 2.576

4.  ADHD: Is Objective Diagnosis Possible?

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  Psychiatry (Edgmont)       Date:  2005-11

Review 5.  The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review.

Authors:  Charlotte L Hall; Althea Z Valentine; Madeleine J Groom; Gemma M Walker; Kapil Sayal; David Daley; Chris Hollis
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-11-30       Impact factor: 4.785

6.  Development of visual attention skills in prelingually deaf children who use cochlear implants.

Authors:  D L Horn; R A O Davis; D B Pisoni; R T Miyamoto
Journal:  Ear Hear       Date:  2005-08       Impact factor: 3.570

7.  Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.

Authors:  Chris Derauf; Barry M Lester; Nurunisa Neyzi; Minal Kekatpure; Luis Gracia; James Davis; Kalpana Kallianpur; Jimmy T Efird; Barry Kosofsky
Journal:  Dev Neurosci       Date:  2012-08-17       Impact factor: 2.984

8.  Impact of prenatal cocaine exposure on attention and response inhibition as assessed by continuous performance tests.

Authors:  Veronica H Accornero; Alfred J Amado; Connie E Morrow; Lihua Xue; James C Anthony; Emmalee S Bandstra
Journal:  J Dev Behav Pediatr       Date:  2007-06       Impact factor: 2.225

9.  DSM-IV diagnoses and obstructive sleep apnea in children before and 1 year after adenotonsillectomy.

Authors:  James E Dillon; Sarah Blunden; Deborah L Ruzicka; Kenneth E Guire; Donna Champine; Robert A Weatherly; Elise K Hodges; Bruno J Giordani; Ronald D Chervin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-11       Impact factor: 8.829

10.  Aberrant Structural Brain Connectivity in Adolescents with Attentional Problems Who Were Born Prematurely.

Authors:  O Tymofiyeva; D Gano; R J Trevino; H C Glass; T Flynn; S M Lundy; P S McQuillen; D M Ferriero; A J Barkovich; D Xu
Journal:  AJNR Am J Neuroradiol       Date:  2018-10-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.